Study Summary:
We are currently conducting a multicenter, randomized, double-blind, parallel group study to evaluate the efficacy and safety of two doses of XXXX-XXXXX versus Placebo in Women with Overactive Bladder.
Qualified Participants Must:
• Be a women age 18 and older
•
Be experiencing overactive bladder symptoms with urgency for over 6 months
•
Have not had three or more urinary tract infections in the past year
Qualified Participants May Receive:
Study related exams, lab tests, and study drug at no charge. Compensation for your time and travel may be available.